ERBB2 and breast carcinoma: In order to more precisely compare HER2 expression levels between used breast cancer cell lines: MDA-MB-231, T-47-D, MDA-MB-453 and SK-BR-3, we carried out a densitometric quantification on the anti-HER2 Western blots published previously [19].